Innovative Health Sciences

Innovative Health Sciences (IHS) is a medical device company focused on the development and commercialization of next-generation infusion technologies. The company's flagship product, the Insignis Syringe Infusion System, is a non-electric, mechanical infusion pump designed for both subcutaneous and intravenous administration. This system is particularly suited for patients with primary immunodeficiency and chronic inflammatory demyelinating polyneuropathy (CIDP) who require regular immunoglobulin therapy. IHS aims to provide cost-effective, portable, and user-friendly solutions that improve the home-care experience for patients. The company was founded by Andrew Sealfon, a pioneer in the infusion pump industry who previously founded Repro-Med Systems.